Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that hair loss from CCCA may be genetic and not solely caused by hair grooming practices.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

FAPD is a possible diagnosis for hair loss in patients of color and requires multiple evaluations for accurate diagnosis.

A patient had both chronic cutaneous lupus erythematosus and frontal fibrosing alopecia.

Infrared thermography, especially with dermoscopy, improves accuracy in diagnosing active hair loss due to inflammation.

Hair restoration surgery can potentially treat primary scarring alopecias, but it's important to start early medication, ensure patient remission before transplant, and monitor after surgery.

A mother and daughter with similar hair loss conditions and identical HLA types suggest a genetic link between the conditions.

Retinoids can prevent skin cancer in high-risk people but have side effects and require more research on dosing and effectiveness.

Woman's hair loss diagnosis changed from CTE to AA; multiple biopsies important for accurate diagnosis.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

Low-Level Light Therapy significantly reduced inflammation and promoted hair regrowth in patients with Lichen planopilaris.

CCCA is a common, progressive hair loss condition that may not always be linked to hair care practices and requires a biopsy for diagnosis.

Hair transplant and applying 5% minoxidil solution can effectively treat permanent hair loss, but it may change hair direction in some cases.

Early and aggressive treatment can significantly regrow hair in discoid lupus erythematosus.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

EMS and EF both show similar skin and fascia changes, but EMS has more severe symptoms and nerve inflammation.

LALPS causes non-scarring hair loss along the Blaschko line, with unique trichoscopic findings.

More vellus hairs in frontal scalp indicate early female pattern hair loss.

Syphilis can cause hair loss and should be considered in unexplained cases.

Increased mucin in the skin might indicate lupus in patients with hair loss, but more research is needed.

Actinic superficial folliculitis is a unique skin condition caused by intense heat and sweating.

Frontal fibrosing alopecia is linked to hypothyroidism but doesn't affect quality of life.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

A male patient developed frontal fibrosing alopecia after antiandrogen therapy for prostate cancer.

A woman's ovarian tumor causing high testosterone was successfully removed, and her symptoms improved.

The new hair loss treatment kit was safe and improved hair growth without any adverse effects.

Nonsteroid treatments for alopecia areata show promise but need more high-quality research.

The review suggests there's no agreed treatment for Frontal Fibrosing Alopecia, but hydroxychloroquine and 5a-reductase inhibitors are most effective. New treatments like platelet-rich plasma and LED light could help if standard treatments fail.

Microneedling combined with skinbooster effectively treats striae rubrae, with confocal microscopy confirming collagen changes.

Researchers found a new early sign of Frontal Fibrosing Alopecia that could help avoid misdiagnosis.